Strategy

Americans hate big pharma more than they do the government (but they still really dislike the government)

The pharmaceutical industry ranks below all other public and private sectors in favorability among Americans, according to a new Gallup poll. Earlier this year, Congress grilled pharmaceutical leaders for charging high prices for prescription drugs. Other top-hated industries include the federal government, healthcare, and the legal field. Visit Business Insider’s […]
Americans hate big pharma more than they do the government (but they still really dislike the government)
News

A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political crosshairs

On Monday, diabetes drugmaker Eli Lilly said it plans to make an “authorised generic” version of its life-saving diabetes medication Humalog and sell it for half the price of the branded version. Humalog is a type of short-acting insulin, which helps people with diabetes process the sugar in their blood. […]
A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political crosshairs
News

Why insulin is so expensive

Colorado became the first state to pass a bill capping the monthly cost of insulin per resident at $US100. Type 1 diabetics need insulin to survive. Due to drastic price increases, many diabetics are struggling to afford the lifesaving drug. In the past 15 years, insulin prices have tripled. There […]
Why insulin is so expensive
News

Everybody is talking about the high cost of prescription drugs. Here’s who’s actually responsible for the prices you pay.

In February, Congress brought in a group of pharmaceutical CEOs and executives from seven companies to testify about the high price of prescription drugs. On Tuesday, Congress is set to keep the conversation going, this time grilling pharmacy benefit managers, the little-known middlemen responsible for negotiating lower drug prices. From […]
Everybody is talking about the high cost of prescription drugs. Here’s who’s actually responsible for the prices you pay.
News

Dispensed: What we saw at JPMorgan’s big healthcare investor conference

Hello, It’s been a long, exciting albeit tiring week for the healthcare team as we made our way around San Francisco’s Union Square during the J.P. Morgan Healthcare Conference. Hills were climbed, cricket tacos consumed, and healthcare discussed at length. Many, many stories ahead from those conversations. But to start, […]
Dispensed: What we saw at JPMorgan’s big healthcare investor conference
Markets

Bristol-Myers Squibb is buying Celgene in a $74 billion deal

Bristol-Myers Squibb has agreed to acquire Celgene, the drugmakers announced Thursday in a deal valued at $US74 billion. The deal will pay Celgene shareholders one BMS share and $US50 cash for each Celgene share they own. The deal combines a massive pharmaceutical company with a biotech giant, both of which […]
Bristol-Myers Squibb is buying Celgene in a $74 billion deal
News

Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses.

There’s been a recent resurgence of interest in psychedelic drugs’ potential to address conditions like anxiety and depression. Venture firms and researchers are on it. This week, the world’s first psychedelics-only VC launched in Canada, Business Insider reported exclusively. Scientists are studying drugs including mushrooms, ecstasy (MDMA), and ketamine – […]
Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses.